{
    "2021-04-12": [
        [
            {
                "time": "2023-04-15",
                "original_text": "一季报又有重磅持股信息，刘格菘“独宠”这家公司",
                "features": {
                    "keywords": [
                        "一季报",
                        "刘格菘",
                        "持股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-04-16",
                "original_text": "安信证券：健帆生物(300529.SZ)血液灌流权威学术体系搭建再下一城，维持“买入-A”评级",
                "features": {
                    "keywords": [
                        "安信证券",
                        "健帆生物",
                        "血液灌流",
                        "买入-A"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-04-17",
                "original_text": "健帆生物(300529.SZ)一季度归母净利同比增长53.62%至2.83亿元",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "归母净利",
                        "同比增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-04-18",
                "original_text": "健帆生物(300529.SZ)一季度净利润升53.62%至2.83亿元",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "净利润",
                        "增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-04-19",
                "original_text": "健帆生物：一季度净利润同比增长53.62%",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "净利润",
                        "增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-04-20",
                "original_text": "高瓴资本概念股普遍下滑，公牛集团、泰格医药、健帆生物、凯莱英领跌",
                "features": {
                    "keywords": [
                        "高瓴资本",
                        "健帆生物",
                        "下滑",
                        "领跌"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-04-21",
                "original_text": "2020年财报亮眼，股权激励下业绩或再提速，血液灌流器龙头健帆生物势不可挡",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "财报",
                        "股权激励",
                        "业绩提速"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-04-22",
                "original_text": "近一周22家公司获机构扎堆调研！",
                "features": {
                    "keywords": [
                        "机构调研",
                        "公司"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合行业"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-04-23",
                "original_text": "医药与健康护理行业周报：年报一季报相继披露 看好业绩确定性高的医药白马",
                "features": {
                    "keywords": [
                        "医药",
                        "健康护理",
                        "年报",
                        "一季报",
                        "业绩确定性"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-04-24",
                "original_text": "安信证券--健帆生物：肾病产品卫生经济学研究数据发布，血液灌流权威学术体系搭建再下一城【公司研究】",
                "features": {
                    "keywords": [
                        "安信证券",
                        "健帆生物",
                        "肾病产品",
                        "卫生经济学",
                        "血液灌流"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}